Skip to main content

Table 2 Differences in outcome measures between intervention- and routine care groups in the MILE-study at 6 and 12 months’ follow-up

From: Effects of a motivational, individual and locally anchored exercise intervention (MILE) on cardiorespiratory fitness: a community-based randomised controlled trial

   6 months’ follow-up   12 months’ follow-up
  n
Intervention/Routine care
Intervention Change from baseline, mean (95% CI) Routine care Change from baseline, mean (95% CI) ∆ between groups (95% CI) n
Intervention/Routine care
Intervention Change from baseline, mean (95% CI) Routine care Change from baseline, mean (95% CI) ∆ between groups (95% CI)
PRIMARY OUTCOME
 VO2max (ml/kg/min) 80/69 2.3 (1.5;3.2)* 1.9 (1.1;2.7)* − 0.5 (− 1.6;0.7) 66/47 3.8 (2.6;5.0)* 3.5 (1.7;5.2)* − 0.3 (− 2.3;1.6)
 VO2max (l/min) 80/69 0.2 (0.1;0.3)* 0.1 (0.1;0.2)* − 0.0 (− 0.1;0.1) 66/47 0.3 (0.2;0.4)* 0.2 (0.1;0.4)* − 0.1 (− 0.2;0.1)
SECONDARY OUTCOMES
 Weight (kg) 81/73 − 0.9 (− 1.6;-0.2) − 0.7 (− 1.5;0.2) 0.3 (− 0.8;1.4) 71/58 −1.2 (− 2.3;-0.0) −0.6 (− 2.3;1.2) 0.6 (− 1.4; 2.6)
 BMI (kg/m2) 81/73 −0.3 (− 0.5;-0.1) −0.2 (− 0.5;0.1) 0.1 (− 0.3;0.4) 71/58 −0.3 (− 0.7;0.0) −0.1 (− 0.7;0.4) 0.2 (− 0.4;0.8)
 Waist circumference (cm)   N/A N/A N/A 70/56 −2.7 (−4.3;-1.1)* − 3.5 (− 5.2;-1.8)* − 0.8 (− 3.1;1.5)
 SF-12 mental score, n (%)   N/A N/A N/A 67/49 0.5 (−2.5;3.4) 0.5 (− 1.9;3.0) 0.1 (− 3.9;4.0)
Accelerometer measured physical activity, min/day
 Sedentary (0–100 cpma) 70/61 5.5 (− 12.2;23.1) −6.7 (− 29.4;16.0) −12.1 (− 40.2;16.0) 48/35 9.7 (− 13.1;32.4) 6.0 (− 18.4;30.3) −3.7 (− 37.0; 29.6)
 Light (101–1951 cpm) 70/61 −4.4 (− 16.2;7.3) −4.8 (− 20.9;11.3) −0.4 (− 19.8;19.0) 48/35 −4.3 (− 21.6;13.0) −12.3(− 25.6;1.0) −8.0 (− 30.9;15.0)
 Moderate to vigorous (> 1951 cpm)b 70/61 1.5 (− 5.8;8.8) −1.7 (− 6.3;2.9) −3.2 (− 12.0;5.6) 48/35 −3.9 (− 9.0;1.2) −6.3 (− 11.1;-1.6) −2.5 (− 9.6;4.6)
Self-reported physical activity
 Moderate to vigorous > 30 min (days/week) 81/74 −0.8 (−1.2;-0.4) −0.8 (− 1.3;-0.2) −0.0 (− 0.7;0.7) 71/56 −0.8 (− 1.4;-0.2) −0.5 (− 1.1;0.1) 0.3 (− 0.6;1.1)
 Very vigorous > 20 min (days/week) 81/74 −0.1 (− 0.5;0.2) −0.4 (0.9;0.0) −0.3 (− 0.8;0.3) 71/56 −0.3 (− 0.6;0.1) −0.4 (− 1.0;0.1) −0.2 (− 0.8;0.5)
LDL (mmol/l)   N/A N/A N/A 63/52 0.2 (− 0.0;0.3) 0.0 (− 0.1;0.2) − 0.1 (− 0.4;0.1)
HDL (mmol/l)   N/A N/A N/A 70/54 0.0 (− 0.0;0.1) 0.0 (− 0.0;0.1) −0.0 (− 0.1;0.1)
HbA1c (mmol/mol)   N/A N/A N/A 70/56 − 0.1 (− 0.5;0.3) −0.0 (− 0.6;0.5) 0.1 (− 0.6;0.8)
Triglyceride (mmol/l)   N/A N/A N/A 70/55 −0.2 (− 0.5;0,2) −0.2 (− 0.5;0.0) −0.0 (− 0.5;0.4)
  1. *t-test of significance p ≤ 0.05
  2. acounts per minute
  3. bDue to less than two minutes (mean) in vigorous and very vigorous activity at follow-up, these categories were added to the moderate activity category